Effect of TECAR therapy and neurodynamic techniques in treatment of carpal tunnel syndrome.

Not Applicable

Recruiting

• Conditions: G56.0; Carpal Tunnel Syndrome.; Carpal tunnel syndrome

• Registration Number: IRCT20191208045652N3
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients with age range of 18-60 years ol
Pain and paresthesia in at least 2 fingers of 3/5 lateral fingers for 1-6 months.
Diagnosis of CTS based on EMG tests (distal motor latency>4m.s and distal sensory latency >5/3 m.s)
Positive Phalen and Tinel test
Ability to read and write in Persian

Exclusion Criteria

pregnancy
Thenar atrophy
history of any hand or wrist surgery
Metabolic diseases (Diabetes mellitus, thyroid or kidney problem)
cervical radiculopathy
Fibromyalgia or other musculoskeletal disorders
Any history of severe trauma to the wrist and Connective tissue disorders
Patient dissatisfaction with the continuation of the treatment and evaluation process

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: At the beginning and the end of each session and two months after the end of the last treatment session. Method of measurement: visual analogue scale.

Secondary Outcome Measures

Name	Time	Method
Grip strength. Timepoint: At the beginning and the end of each session and two months after the end of the last treatment session. Method of measurement: Hand held dynamo meter.;Functional status scale of Boston questionnaire. Timepoint: Before treatment, at the end of third session and two months after the end of the last treatment session. Method of measurement: Persian Boston Questionnaire.;Symptom severity scale of Boston Questionnaire. Timepoint: Before treatment, at the end of third session and two months after the end of the last treatment session. Method of measurement: Persian Boston Questionnaire.